The week started off with a clinical bang for Verona Pharma, Kodiak, AstraZeneca and Daiichi Sankyo as these companies posted promising data in chronic obstructive pulmonary disease (COPD), lung cancer, and macular edema respectively.
https://www.pharmalive.com/wp-content/uploads/2022/08/BioSpacemicroscope8-9-2022.jpg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2022-08-09 08:00:322022-08-09 12:08:25Verona, Daiichi Sankyo, AstraZeneca and Kodiak score big wins in key diseases
